This week, healthcare's three biggest pressure points converged. The largest consumer AI deployment in history is rolling out to 20 million members while most health systems still can't govern the AI their own clinicians are already using. Pharma is spending billions to outrun patent cliffs. And Medicaid is being restructured in ways that threaten the hospitals serving the communities with the highest need. The thread connecting all of it: the gap between what the system is building and who it's leaving behind is widening, not closing.
Vitals
- UnitedHealth's Avery AI is scaling to 20.5 million members by year-end, the largest consumer healthcare AI deployment in the country
- Merck paid $6.7 billion for Terns Pharmaceuticals, the latest mega-deal in pharma's scramble to replace $200B+ in expiring blockbuster patents
- Medicaid work requirements are being mandated nationally, but Georgia's pilot enrolled only 8,000 of 240,000 eligible, with 22% denied for paperwork alone
- Healthcare staffing market projected to nearly double from $45B to $90B by 2033 as workforce shortages become permanent
- AI psychiatry startup Blossom Health raised $20M to pair clinicians with AI copilots, addressing 30-day wait times for mental health care
Peaks
UnitedHealth Scales Avery AI to 20.5M Members
UnitedHealth Group's generative artificial intelligence companion "Avery" is now projected to reach 20.5 million commercial, Medicare, and Medicaid members by the end of 2026. The AI-powered tool, designed for customer-facing roles, represents the largest deployment of consumer healthcare AI in the United States.
The rollout comes as UnitedHealth seeks to improve operating leverage and member retention through automated engagement. Early deployments show promise in reducing call center volumes and improving member satisfaction scores. The platform leverages large language models to handle routine inquiries, prescription questions, and benefit explanations.
Why it matters: Management expects Avery to generate significant cost savings while positioning UnitedHealth ahead of competitors in the AI-driven healthcare engagement race. The massive scale gives the company unprecedented data to refine AI responses and member experience optimization.
Blossom Health Secures $20M for AI Psychiatry Platform
New York-based telepsychiatry startup Blossom Health raised $20 million across seed and Series A funding rounds led by Headline. The company's AI-powered "operating system for psychiatry" pairs licensed clinicians with AI copilots for scheduling, billing, and documentation.
The platform addresses critical workforce shortages in mental health by automating administrative tasks that consume up to 40% of clinician time. Blossom's artificial intelligence (AI) handles appointment scheduling, insurance verification, and clinical note generation, allowing psychiatrists to focus on patient care.
Why it matters: The funding comes as mental health demand surges nationwide, with wait times for psychiatric care exceeding 30 days in most metropolitan areas. Investors see AI-augmented mental healthcare as essential infrastructure for addressing the growing behavioral health crisis.
Merck's $6.7B Terns Acquisition Signals Patent Cliff Strategy
Merck announced the acquisition of Terns Pharmaceuticals for $6.7 billion, securing TERN-701, a novel chronic myeloid leukemia (CML) candidate, as the company prepares for Keytruda's patent expiration. The deal, expected to close in Q2 2026, represents one of the largest biotech acquisitions this year.
The acquisition reflects Big Pharma's aggressive approach to replacing blockbuster drugs facing patent cliffs. Keytruda, which generated over $25 billion in 2025 revenue, faces generic competition by 2028. Terns' pipeline provides potential replacement revenue streams in hematology and oncology.
Why it matters: The transaction signals intensifying competition for late-stage biotech assets as pharmaceutical giants scramble to fill revenue gaps. Analysts expect similar mega-deals throughout 2026 as patent expirations accelerate across the industry.
Troughs
Medicaid Work Requirements Threaten Hospital Closures
New analysis reveals that extending Medicaid work requirements nationally could result in coverage loss for half of current beneficiaries, threatening hundreds of hospitals with closure. Georgia's Pathways program, launched in 2023, has enrolled far fewer participants than projected.
Safety-net hospitals in rural and urban areas with high uninsured populations face the greatest risk. Emergency department volumes and uncompensated care costs are projected to surge as individuals lose coverage. Hospital systems in expansion states are already delaying workforce investments pending clarity on federal policy direction.
Why it matters: The American Hospital Association warns that communities with highest chronic disease burden will bear disproportionate impact. Emergency care access could be severely compromised in areas where hospitals are forced to reduce services or close entirely.
Hospital Workforce Cuts Continue Across Multiple States
Healthcare workforce reductions accelerated in March 2026, with multiple health systems announcing layoffs affecting thousands of positions. Economic pressures from reduced reimbursements and post-pandemic financial strain continue forcing difficult staffing decisions.
The cuts span clinical and administrative roles, with particular impact on support services and community health programs. Labor costs, which comprise 50-60% of hospital expenses, remain the primary target for systems seeking financial stability.
Why it matters: Healthcare employment, previously recession-resistant, now faces structural challenges as organizations balance quality care delivery with fiscal sustainability. The reductions compound existing workforce shortages in nursing, pharmacy, and allied health professions.
AI Governance Gap Widens in Healthcare Organizations
Despite massive artificial intelligence (AI) investments, healthcare organizations struggle to operationalize AI at scale. New research reveals that approximately 75% of AI-enabled medical devices cleared by U.S. Food and Drug Administration (FDA) regulators focus on radiology, highlighting narrow deployment despite broad potential applications.
The gap between AI investment and enterprise value remains significant across healthcare systems. Organizations report difficulty coordinating AI initiatives beyond isolated use cases, with governance frameworks failing to keep pace with technological capabilities.
Why it matters: Trust and accountability concerns limit broader AI deployment in patient care settings. Healthcare leaders cite regulatory uncertainty, liability questions, and staff training gaps as primary barriers to expanding AI beyond administrative functions.
Trends
Revenue Cycle AI Arms Race Intensifies
Healthcare revenue cycle management is experiencing an AI transformation, with startups like Adonis securing $40 million in Series C funding to combat escalating payer denials. The company's "agentic AI" platform automates prior authorization, claims processing, and denial appeals.
Payer denial rates continue climbing across the industry, creating urgent demand for AI-powered revenue cycle solutions. Healthcare systems report denial management consuming 25-30% of revenue cycle staff time, making automation essential for financial sustainability.
Why it matters: The revenue cycle AI market is attracting significant venture investment as health systems seek tools to navigate increasingly complex payer requirements. Integration with existing electronic health records and billing systems remains a key competitive differentiator.
Healthcare Staffing Market Projected to Double
The U.S. healthcare staffing market is projected to reach approximately $90 billion by 2033, driven by persistent workforce shortages and aging population demographics. Travel nursing, locum tenens, and per-diem staffing represent the fastest-growing segments.
Hospitals increasingly rely on contingent workforce models to address gaps in critical specialties including emergency medicine, intensive care, and surgical services. Premium rates for specialized temporary staff are driving market expansion despite cost pressures on health systems.
Why it matters: Technology platforms connecting healthcare facilities with temporary staff are attracting significant investment. AI-powered matching algorithms and streamlined credentialing processes are reducing time-to-placement and improving workforce efficiency.
Federal vs State AI Regulation Creates Fragmentation
The White House released a National Policy Framework for Artificial Intelligence proposing federal preemption of state AI laws that impose "undue burdens." The framework aims to prevent regulatory fragmentation as states like California, New York, and Colorado advance comprehensive AI legislation.
Healthcare organizations face increasing complexity navigating different AI requirements across jurisdictions. The framework calls for sector-specific regulation through existing bodies rather than creating new federal AI oversight agencies.
Why it matters: State AI laws scheduled to take effect in 2026, including Colorado's comprehensive AI Act, create uncertainty for healthcare AI developers and implementers. The tension between federal coordination and state innovation continues shaping the regulatory landscape.
So What?
Three forces collided this week that will shape the next 18 months of healthcare. First, the AI deployment gap: UnitedHealth is rolling out consumer AI to 20 million members while most health systems can't govern the AI their own clinicians are already using in the shadows. The organizations that build governance infrastructure now will own the market. The ones that don't will face liability crises when unauthorized clinical AI use inevitably produces a high-profile error.
Second, the workforce math is broken and not coming back. Healthcare staffing is projected to double to $90 billion because the underlying shortage is structural, not cyclical. Every hospital cutting staff this quarter is simultaneously paying premium rates for temporary replacements. That's not a strategy. That's a system failing in slow motion.
Third, the safety net is being pulled apart from both ends. Medicaid work requirements are creating administrative barriers that deny coverage for paperwork failures, not ineligibility. At the same time, hospital layoffs are removing the care infrastructure those communities depend on. The communities with the highest chronic disease burden are losing both insurance coverage and the providers who serve them, simultaneously.
For Professionals
If your organization hasn't established clear policies on clinical AI use, you're operating in a liability gray zone. Every clinician using ChatGPT or public AI tools for clinical reasoning without institutional oversight is creating unmanaged risk. The question isn't whether to use AI. It's whether you're using it with governance or without it.
For Leaders
Merck didn't spend $6.7 billion because they had time to wait. The patent cliff is forcing pharma to make acquisition decisions at a pace that benefits sellers. If your organization has a product, platform, or data asset that pharma needs, the next 24 months is the window. After that, the deals get smaller and the leverage shifts. The same urgency applies to AI governance: build the framework now or inherit someone else's liability later.
For Builders
The healthcare staffing market doubling to $90 billion means any platform that reduces recruiter-to-candidate friction has a massive addressable market. AI credentialing, predictive workforce matching, and compliance automation are the highest-value build opportunities right now. Meanwhile, revenue cycle AI (Adonis raised $40M) is proving that payer complexity is a feature, not a bug, for the right technology. Where there's administrative pain, there's a business.
On the Calendar
- BHC NMAC Chicago Community Connect — April 10
- BHC Central Florida Mixer — April 16
- BHC Los Angeles Mixer — April 17
- BHC Philadelphia Mixer — April 23
- BHC Nashville Mixer — April 24